An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

BioCryst sees strong ORLADEYO growth and improved guidance, targeting 2025 profitability. Click here to read an analysis of ...

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

This study provides valuable insights into the crosstalk between ATG2A with components of the early secretory pathway, namely RAB1A and ARFGAP1. The evidence supporting the claims is convincing.

The Department of Biotechnology’s BioE3 policy-short for Biotechnology for Economy, Environment, and Employment is in motion. A national call has been issued for setting up Bio-AI hubs and build new ...

Prediabetes affects nearly one in three Americans. Most people with this condition are likely to develop Type 2 diabetes if ...

Steven Williams was prescribed a two-week course of antibiotics but says it was too late for them to be effective ...